FDA Person
Office of the CommissionerJolanna A.
View detailed information about Jolanna A., including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of the Commissioner.
Documents (13)
- 483 RESPONSE · Alexion Pharmaceuticals, Inc. · August 6, 2012
- WARNING LETTER RESPONSE · Invacare Corporation · June 30, 2011
- WARNING LETTER RESPONSE · Invacare Corporation · April 25, 2011
- STATE REFERRAL LETTER · Nebraska Methodist Hospital · December 13, 2015
- EIR · Abbott Laboratories · September 24, 2021
- EIR · Eli Lilly & Company · January 17, 2020
- EIR · Abbott Laboratories · September 24, 2019
- STATE REFERRAL LETTER · Clinical Apothecaries · November 13, 2013
- EIR · Abbott Laboratories · September 18, 2018
- 483 · Wedgewood Connect, LLC · July 3, 2025
- 483 · McKesson Corporation Headquarters · July 3, 2018
- 483 · Integrated Health Concepts Inc. · July 23, 2021
- 483 · Daiichi Sankyo Chemical Pharma Co., Ltd. · December 22, 2023
Related Office
Person Information
Name
Jolanna A.
Title
Medical Content Writer
Role
Regulatory Personnel
ID: 204c4fa5-c69c-4ed4-8800-267788e163d2
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.